Fibrosing Interstitial Lung Disease

• CLINICAL_TRIALS research · 2026-04-21
  Clinical Trial Update: FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression [Phase 3]

  A Phase 3 trial named FIBRONEER-ACT is evaluating nerandomilast for fibrosing interstitial lung disease at risk for progression. The study i…

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease [Phase 3]

  Phase 3 clinical trial evaluating nerandomilast in children and adolescents with fibrosing interstitial lung disease to assess tolerability,…

• CLINICAL_TRIALS trial_result · 2026-02-06
  Clinical Trial Update: Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan

  A post-marketing surveillance study of Ofev (nintedanib) in Japanese patients with chronic fibrosing interstitial lung diseases with a progr…

• CLINICAL_TRIALS trial_result · 2025-06-22
  Clinical Trial Update: Telerehabilitation in Patients With Fibrosing Interstitial Lung Diseases [NA]

  This clinical trial update notes the completion of a study evaluating telerehabilitation for patients with fibrosing interstitial lung disea…

• CLINICAL_TRIALS research · 2025-06-04
  Clinical Trial Update: Evaluation of Frailty in Patients With Fibrosing Interstitial Lung Diseases: Prognostic and Therapeutic Impact

  Clinical trial evaluating frailty in patients with fibrosing interstitial lung diseases to determine prognostic and therapeutic impact, with…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-04-25
  Clinical Trial Update: INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation

  The real-world INREAL study reports results of nintedanib (Ofev) in patients with chronic fibrosing interstitial lung disease with a progres…

• CLINICAL_TRIALS research · 2025-03-03
  Clinical Trial Update: Prospective Cohort of Patients With Fibrosing Interstitial Lung Disease Admitted for Acute Respiratory Failure

  A prospective cohort study is being conducted in patients with fibrosing interstitial lung disease admitted for acute respiratory failure; t…

• FDA approval · 2016-02-04
  FDA Approved: OFEV — Supplemental Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

  FDA approved a supplemental application for OFEV (nintedanib) filed by Boehringer Ingelheim Pharmaceuticals, Inc., expanding its approved us…